Addpharma Inc.

This early-stage study tests a new drug for mixed dyslipidemia (high cholesterol and fats in the blood) in 60 healthy adults. Participants will receive two versions of the drug at different times to compare how the body absorbs and processes them. The goal is to gather safety and…

This study tests a new drug called AD-211 for people with knee osteoarthritis. The goal is to find the best dose to reduce pain during activity. About 200 participants will receive either AD-211 or a placebo in a double-blind setup, meaning neither they nor their doctors will kno…

This early-stage study looks at how three experimental drugs (AD-231A, AD-231B, and AD-231C) interact in the body. It involves 55 healthy adults aged 19 to 64. The goal is to measure drug levels and check for safety, not to treat any condition.

This early-stage study tests a new drug called AD-230 in 52 healthy adults aged 19 to 64. The goal is to measure how the drug moves through the body and to check for any safety concerns. Participants will receive the drug in two different ways (order decided by chance) so researc…

This early-stage study tests two different forms of a drug (AD-116 and AD-1161) in 44 healthy adult men to see how they are processed in the body and if they are safe. The study does not treat any disease. It is designed to gather information on drug levels and safety under fasti…